Aerovate Therapeutics Inc...

NASDAQ: AVTE · Real-Time Price · USD
2.68
0.00 (0.00%)
At close: Apr 28, 2025, 3:59 PM

Aerovate Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-69.63M -75.52M -51.51M -22.96M
Depreciation & Amortization
282K 96K 68K 15K
Stock-Based Compensation
11.31M 11.91M 5.48M 2.04M
Other Working Capital
-11.17M 9.96M 6.39M -7.12M
Other Non-Cash Items
-1.99M -3.06M -910K 16K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-11.17M 9.8M 7.75M -6.51M
Operating Cash Flow
-71.2M -56.78M -39.12M -27.4M
Capital Expenditures
n/a -142K -195K -181K
Cash Acquisitions
n/a n/a -7.12K n/a
Purchase of Investments
n/a -123.98M -147.62M -113.25M
Sales Maturities Of Investments
n/a 136M 154.74M n/a
Other Investing Acitivies
56.03M n/a 7.12K -113.25K
Investing Cash Flow
56.03M 11.88M 6.93M -113.43M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
1.49M 1.11M 396K n/a
Financial Cash Flow
25.43M 46M 396K 190.46M
Net Cash Flow
10.26M 1.09M -31.8M 49.62M
Free Cash Flow
-71.2M -56.92M -39.32M -27.58M